How many batches shall be subjected for In-use stability
testing during stability study?
|
1.According to EMA Guidance “Note for Guidance on In-use Stability
Testing of Human Medicinal Products”
“A
minimum of two batches, at least pilot scale batches, should be subjected to
the test. At least one of the batches should be chosen towards the end of its
shelf life. If such results are not available, one batch should be tested at
the final point of the submitted stability studies”.
“If
the product is to be supplied in more than one container size or in different
strengths, the in-use stability test should be applied to the product which
presents the greatest susceptibility to change. The choice of the tested
product should always be justified”.
2.According to USFDA Guidance “ANDA Submissions — Content and
Format Guidance for Industry”
“One-time
in-use stability studies for oral liquids and other dosage forms (e.g., a
solution to be used within a certain period of opening the container per
labeling instructions, compatibility with a dropper when provided as part of
the container closure system), as applicable”.
|
Pharma treasures is an informatory site, which shares pharma related articles. The ultimate goal of this site is to become a knowledge hub by gathering all pharma related technical information under one roof...... This blog mainly talks about QMS,cGMP,Regulatory Filings & Guidelines,Validation & Qualifications,Drug Stability,FDA 483s &Media Fill. Hope this blog will cater the needs of both fresher’s and experienced professionals.
Sunday, 2 February 2020
Stability Testing Question & Answers; In-use Testing Requirements
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment